Evidence map›Paper›PMID 32638023›Full record

ArticleThe Journal of infectious diseases2021

Elevated Blood Mitochondrial DNA in Early Life Among Uninfected Children Exposed to Human Immunodeficiency Virus and Combination Antiretroviral Therapy in utero.

Abhinav Ajaykumar, Mayanne Zhu, Fatima Kakkar, Jason Brophy, Ari Bitnun, Ariane Alimenti, Hugo Soudeyns, Sara Saberi, Arianne Y K Albert, Deborah M Money and 2 more

Open access · greenAbstract read
In one paragraph

Article in The Journal of infectious diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Abhinav AjaykumarDepartment of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Mayanne ZhuDepartment of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Fatima KakkarDepartment of Pediatrics, CHU Sainte-Justine, Université de Montréal, Montreal, Quebec, Canada.
Jason BrophyDepartment of Pediatrics, Children's Hospital of Eastern Ontario, University of Ottawa, Ottawa, Ontario, Canada.
Ari BitnunDepartment of Pediatrics, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
Ariane AlimentiDepartment of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada.
Hugo SoudeynsUnité d'Immunopathologie Virale, Centre de Recherche du CHU Sainte-Justine, Montreal, Quebec, Canada.
Sara SaberiDepartment of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Arianne Y K AlbertWomen's Health Research Institute, Vancouver, British Columbia, Canada.
Deborah M MoneyBC Women's Hospital and Health Centre, Vancouver, British Columbia, Canada.
Hélène C F CôtéDepartment of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
CIHR Team in Cellular Aging and HIV Comorbidities in Women and Children (Children and Women: AntiRetrovirals and Markers of Aging [CARMA])
University of British Columbia · CACentre Hospitalier Universitaire Sainte-Justine · CAUniversity of Ottawa · CAUniversity of Toronto · CAWomen's Health Research Institute · CA

Funding

CIHR HET-85515
6 · The paper itself

Abstract

backgroundCombination antiretroviral therapy (cART) during pregnancy prevents vertical transmission, but many antiretrovirals cross the placenta and several can affect mitochondria. Exposure to maternal human immunodeficiency virus (HIV) and/or cART could have long-term effects on children who are HIV exposed and uninfected (CHEU). Our objective was to compare blood mitochondrial DNA (mtDNA) content in CHEU and children who are HIV unexposed and uninfected (CHUU), at birth and in early life.

methodsWhole-blood mtDNA content at birth and in early life (age 0-3 years) was compared cross-sectionally between CHEU and CHUU. Longitudinal changes in mtDNA content among CHEU was also evaluated.

resultsAt birth, CHEU status and younger gestational age were associated with higher mtDNA content. These remained independently associated with mtDNA content in multivariable analyses, whether considering all infants, or only those born at term. Longitudinally, CHEU mtDNA levels remained unchanged during the first 6 months of life, and gradually declined thereafter. A separate age- and sex-matched cross-sectional analysis (in 214 CHEU and 214 CHUU) illustrates that the difference in mtDNA between the groups remains detectable throughout the first 3 years of life.

conclusionThe persistently elevated blood mtDNA content observed among CHEU represents a long-term effect, possibly resulting from in utero stresses related to maternal HIV and/or cART. The clinical impact of altered mtDNA levels is unclear.

Indexed as

Prenatal Exposure Delayed EffectsAnti-HIV AgentsAntiretroviral Therapy, Highly ActiveChild, PreschoolCross-Sectional StudiesDNA, MitochondrialFemaleHIV InfectionsHumansInfantInfant, NewbornInfectious Disease Transmission, VerticalLongitudinal StudiesMalePregnancyPregnancy Complications, InfectiousAnti-HIV AgentsDNA, Mitochondrialchildren HIV-exposed uninfectedcombination antiretroviral therapylongitudinal mtDNA contentmitochondrial DNA contentpreterm birth

Identifiers

PMID32638023
PMCPMC7904292
OpenAlexW3041935413

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.